Forty Human Embryonic Stem Cell Lines in 2009

Earlier this month The New York Times reported that the NIH approved an additional 13 human embryonic stem cell lines for use in federally funded research. A couple of weeks later USA Today reported an additional 27 cell lines approved. As of today, there are a total of 40 lines approved by the NIH as eligible for federally funded research—11 from Children’s Hospital Boston, 2 from Rockefeller University, and 27 from Harvard’s Human Embryonic Stem (HUES) Cell Collection. In an NIH press release, Director Francis S. Collins noted: “In accordance with the guidelines, these stem cell lines were derived from embryos that were donated under ethically sound informed consent processes. More lines are under review now, and we anticipate continuing to expand this list of responsibly derived lines eligible for NIH funding.”

In related news coverage, Joe Palca reviews a decade of stem cell research on NPR’s Morning Edition, Reflecting On A Decade Of Stem Cell Research (December 29, 2009).

Related Links:

NIH Stem Cell Informationhttp://stemcells.nih.gov/
Clarification of Terms and Conditions of Awards using Human Embryonic Stem Cells. NOT-OD-10-029. December 14, 2009.
Indiana University Center for Bioethics Stem Cell Study Group. Diverse perspectives: considerations about embryonic stem cell research. Indiana University Center for Bioethics. October, 2002. http://hdl.handle.net/1805/636
Siegel A. Ethics of stem cell research. In Zalta EN, editor. The Stanford Encyclopedia of Philosophy (Fall 2008 Edition).

Other Research Ethics News

Anthony Mathur. Should patients be obliged to take part in research? BBC News. December 9, 2009.

Howard Brody. BMJ: Medical Research is Broken. Hooked: Ethics, Medicine, and Pharma. December 9, 2009.

Related:
Godlee F, Clarke M. Why don’t we have all the evidence on oseltamivir? BMJ. 2009 Dec 8;339:b5351. PMID: 19995815.

Miriam Shuchman. Protecting patients in ongoing clinical trial. CMAJ. December 8, 2009.

Trine Tsouderos and Patricia Callahan. Autism: Kids put at risk. The Los Angeles Times. December 7, 2009.

Serena Golden. ‘Examining Tuskegee’. Inside Higher Ed. December 7, 2009.

Susan M. Reverby. A New Lesson from the Old “Tuskegee” Study. Race-talk. December 3, 2009.

Andre Picard. The man from Pfizer: Should Big Pharma help steer health research? The Globe and Mail. December 2, 2009.

Related:
Stuart Laidlaw. Pfizer Canada facing two conflict fights. Medical Ethics blog (Toronto Star). December 3, 2009.

– J.O.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s